Cost per day in dermatology was $68.76 for ruxolitinib versus $4.29 for tacrolimus, implying marked budget impact despite non-equivalence as clinical substitutes. Phase 3 efficacy and tolerability ...

Although cancer has long been the leading cost driver for employer-sponsored health plans, employers are weighing far more than spending when they evaluate cancer care, according to Karen van Caulil, ...

Clearing hepatitis C sharply reduces liver cancer risk without erasing it. Across 23 studies covering 29,395 patients, HCC occurred at 1.54 per 100 person-years after sustained virologic response ...

Quality & Value Study findings discussed in part 1, Stephen "Fred" Divers, MD, explained how the data reshape the narrative around community oncology's sustainability and value, along with how the ...

Today’s panel will cover steps to close gaps in between innovation and implementation in community oncology. These include efforts to improve AI skills among oncology teams in underserved areas, steps ...

Congress's Mental Health TALK SAFE Act could expand telepsychiatry access by establishing permanent telehealth prescribing and licensing rules. One of us has lost physician colleagues to suicide and ...

Approved CD20×CD3 bispecifics (epcoritamab, glofitamab, mosunetuzumab) deliver meaningful ORR/CR in heavily pretreated DLBCL, but PFS remains modest, motivating combination strategies.

People don’t realize, too, that CAR T, even when it’s done, you still need disease monitoring. There’s B-cell defects ...

Formal care plans that once outlined follow-up steps to catch late toxicities have largely fallen out of use, and even when ...

Ahmed Al-Katib, MD, is a board-certified psychiatrist and founder of Psychiatry in Motion. He completed his psychiatry residency at SUNY Downstate Medical Center and has served as an attending ...

Medicare’s DRG-based inpatient payment and expiring add-on mechanism shift CGT financial risk to hospitals once temporary new ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...